В этой статье мы даем краткий обзор точной прогностической медицины, которая использует современные методы медицинской диагностики, подходы молекулярной медицины и информационной технологии, включая искусственный интеллект и машинное обучение, для анализа медицинских данных в целях улучшения диагностики, прогноза и лечения заболеваний. Развитие точной прогностической медицины меняет традиционный медицинский подход к болезням и пациентам: от реактивной парадигмы реакции на болезнь происходит переход к предсказанию и превентивному лечению хронических заболеваний. Текущие открытия в медицине позволяют углубить понимание причин болезней и разработать новые методы лечения. Одновременно, широкое внедрение высокотехнологичных методов, таких как новые методы медицинской визуализации (например, МРТ, МЭГ, БИКС и др.) и информационные технологии для анализа медицинских и биологических данных, позволяет исследователям и клиницистам иметь новую клиническую и статистическую информацию, значимую для прогноза заболевания конкретного пациента. Все это, а также успехи молекулярной медицины, приводят к значительному росту качества прогноза и лечения заболеваний в кардиологии, онкологии, неврологии и т.д.
2. Hirsch L, Jette N, Frolkis A, Steeves T, Pringsheim T. The incidence of Parkinson’s disease: a systematic review and meta-analysis. Neuroepidemiology. 2016; 46(4): 292-300.
3. Driver JA, Logroscчino G, Gaziano JM, Kurth T. Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology. 2009; 72(5): 432-438.
4. Alzheimer’s Association Report. 2020 Alzheimer’s disease facts and figures. Alzheimer’s Dement. 2020; 16: 391-460.
5. Pravettoni G, Triberti S. A “P5” Approach to Healthcare and Health Technology. In P5 eHealth: An Agenda for the Health Technologies of the Future. 2020; Springer, Cham: 3-17.
6. Hood L. Systems medicine, transformational technologies and the emergence of predictive, personalized, preventive and participatory (P4) medicine. Proceedings of the Conference on High Performance Computing Networking, Storage and Analysis. ACM. 2009.
7. Hood L. Systems biology and p4 medicine: past, present, and future. Rambam Maimonides medical journal. 2013; 4(2).
8. Cesario A, Auffray C, Russo P, Hood L. P4 medicine needs P4 education. Current Pharmaceutical Design. 2014; 20(38): 6071-6072.
9. Pulciani S, Di Lonardo A, Fagnani C, Taruscio D. P4 medicine versus Hippocrates. Annali dell’Istituto superiore di sanita. 2017; 53(3): 185-191.
10. Леонов С.А. Интеграция здравоохранения, образования и информационно-коммуникационных технологий в рамках цифровизации отечественной медицины // Актуальные проблемы экономики и управления. — 2018. — №3. — С.35. [Leonov S.A. Integraciya zdravoohraneniya, obrazovaniya i informacionno-kommunikacionnyh tekhnologij v ramkah cifrovizacii otechestvennoj mediciny. Aktual’nye problemy ekonomiki i upravleniya. 2018; 3: 35. (In Russ).]
11. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proceedings of the National Academy of Sciences. 1998; 95(25): 14863-14868.
12. Nicolini C, Bragazzi N, Pechkova E. Nanoproteomics enabling personalized nanomedicine. Advanced drug delivery reviews. 2012; 64(13): 1522-1531.
13. Cutica I, Mc Vie G, Pravettoni G. Personalised medicine: the cognitive side of patients. European Journal of Internal Medicine. 2014; 25(8): 685-688.
14. Vickers NJ. Animal Communication: When I’m Calling You, Will You Answer Too? Current Biology. 2017; 27(14): R713-R715.
15. Domenighetti G, Grilli R, Liberati A. Promoting consumers’ demand for evidence-based medicine. International Journal of Technology Assessment in Health Care. 1998; 14(1): 97-105.
16. Hood L, Flores M. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. New biotechnology. 2012; 29(6): 613-624.
17. Bellazzi R, Ferrazzi F, Sacchi L. Predictive data mining in clinical medicine: a focus on selected methods and applications. Wiley Interdisciplinary Reviews: Data Mining and Knowledge Discovery. 2011; 1(5): 416-430.
18. Barbolosi D, Ciccolini J, Lacarelle B, Barlési F, André N. Computational oncology — mathematical modelling of drug regimens for precision medicine. Nature reviews Clinical oncology. 2016; 13(4): 242.
19. Грибова В.В., Петряева М.В., Окунь Д.Б., Шалфеева Е.А. Онтология медицинской диагностики для интеллектуальных систем поддержки принятия решений // Онтология проектирования. — 2018. — №8(1). — С.27. [Gribova VV, Petryaeva MV, Okun’ DB, SHalfeeva EA. Ontologiya medicinskoj diagnostiki dlya intellektual’nyh sistem podderzhki prinyatiya reshenij. Ontologiya proektirovaniya. 2018; 8(1): 27. (In Russ).]
20. Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. American journal of human genetics. 1995; 56(1): 265.
21. Carter RF. BRCA1, BRCA2 and breast cancer: a concise clinical review. Clinical and Investigative Medicine. 2001; 24(3): 147.
22. Kujovich JL. Factor v Leiden thrombophilia. Genetics in Medicine. 2011; 13(1): 1-16.
23. Torkamani A, Andersen KG, Steinhubl SR, Topol EJ. High-definition medicine. Cell. 2017; 170(5): 828-843.
24. Tuena C, Semonella M, Fernández-Álvarez J, Colombo D, Cipresso P. Predictive Precision Medicine: Towards the Computational Challenge. In P5 eHealth: An Agenda for the Health Technologies of the Future. 2020. Springer, Cham: 71-86.
25. Strimbu K, Tavel JA. What are biomarkers? Current Opinion in HIV and AIDS. 2010; 5(6): 463.
26. Chen JJ, LuTP, ChenYC, Lin WJ. Predictive biomarkers for treatment selection: statistical considerations. Biomarkers in medicine. 2015; 9(11): 1121-1135.
27. Ginsburg GS, Phillips KA. Precision medicine: from science to value. Health Affairs. 2018; 37(5): 694-701.
28. Wang E, Cho WC, Wong SC, Liu S. Disease biomarkers for precision medicine: challenges and future opportunities. Genomics, proteomics & bioinformatics. 2017; 15(2): 57.
29. Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine. N Engl J Med. 2012; 366(6): 489-491.
30. Mitchell RS, Michalski JG, Carbonell TM. An artificial intelligence approach. 2013. Springer, Berlin.
31. Giger ML. Machine learning in medical imaging. Journal of the American College of Radiology. 2018; 15(3): 512-520.
32. Cipresso P, Matic A, Giakoumis D, Ostrovsky Y. Advances in computational psychometrics. Computational and mathematical methods in medicine, 2015.
33. Leff DR, Yang GZ. Big data for precision medicine. Engineering. 2015; 1(3): 277-279.
34. Obermeyer Z, Emanuel EJ. Predicting the future — big data, machine learning, and clinical medicine. The New England journal of medicine. 2016; 375(13): 1216.
35. Alpaydin Ethem. Introduction to machine learning. MIT press, 2020.
36. Mayer Schönberger V, Ingelsson E. Big Data and medicine: a big deal? Journal of internal medicine. 2018; 283(5): 418-429.
37. Jacob Rodrigues M, Postolache O, Cercas F. Physiological and Behavior Monitoring Systems for Smart Healthcare Environments: A Review. Sensors. 2020; 20(8): 2186.
38. Arac A. Machine Learning for 3D Kinematic Analysis of Movements in Neurorehabilitation. Current Neurology and Neuroscience Reports. 2020; 20(8): 1-6.
39. Wagenaar JB, Worrell GA, Ives Z, Dümpelmann M, Litt B, Schulze-Bonhage A. Collaborating and sharing data in epilepsy research. Journal of clinical neurophysiology: official publication of the American Electroencephalographic Society. 2015; 32(3): 235.
40. Klatt J, Feldwisch Drentrup H, Ihle M, Navarro V, Neufang M, Teixeira C, Le Van Quyen M. The EPILEPSIAE database: An extensive electroencephalography database of epilepsy patients. Epilepsia. 2012; 53(9): 1669-1676.
41. Frey LJ, Bernstam EV, Denny JC. Precision medicine informatics. Journal of the American Medical Informatics Association. 2016; 23(4): 668-670.
42. Hsiao CJ, Hing E, Ashman J. Trends in Electronic Health Record System Use Among Office-based Physicians, United States. 2014. 2007-2012 (No. 75). US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics.
43. Kruse CS, Stein A, Thomas H, Kaur H. The use of electronic health records to support population health: a systematic review of the literature. Journal of medical systems. 2018; 42(11): 1-16.
44. Hecht J. The future of electronic health records. Nature. 2019; 573(7775): S114-S114.
45. GE Healthcare Systems. 2011. Centricity Electronic Medical Record: Experience that counts. URL:http:/www3.gehealthcare.com/media/Downloads/us/Product/Product-Categories/Healthcare%20IT/Electronic%20Medical%20Records/ITP01981010ENUScentricityemrbrochure.pdf?Parent=%7B3FB3AC2B-38EE-4838-B06E-4472AFC090F0%7D.
46. Montvida O, Dibato JE, Paul S. Evaluating the representativeness of US centricity electronic medical records with reports from the centers for disease control and prevention: comparative study on office visits and cardiometabolic conditions. JMIR Medical Informatics. 2020; 8(6): e17174.
47. Brixner D, Said Q, Kirkness C, Oberg B, Ben Joseph R, Oderda G. Assessment of cardiometabolic risk factors in a national primary care electronic health record database. Value in health. 2007; 10: S29-S36.
48. Crawford AG, Cote C, Couto, et al. Comparison of GE Centricity Electronic Medical Record database and National Ambulatory Medical Care Survey findings on the prevalence of major conditions in the United States. Population health management. 2010; 13(3): 139-150.
49. Montvida O, Shaw J, Atherton JJ, Stringer F, Paul SK. Long-term trends in antidiabetes drug usage in the US: real-world evidence in patients newly diagnosed with type 2 diabetes. Diabetes care. 2018; 41(1): 69-78.
50. Lundin P, Eriksson SV, Strandberg LE, Rehnqvist N. Prognostic information from on-line vectorcardiography in acute myocardial infarction. The American journal of cardiology. 1994; 74(11): 1103-1108.
51. Yang L, Xia C, Mu Y, Guan L, Wang C, Tang Q, Shih MC. Prognostic value of real time myocardial contrast echocardiography after percutaneous coronary intervention. Echocardiography. 2016; 33(3): 421-430.
52. Vargas AJ, Harris CC. Biomarker development in the precision medicine era: lung cancer as a Kim case study. Nature Reviews Cancer. 2016; 16(8): 525.
53. Hoggatt J. Personalized Medicine — Trends in Molecular Diagnostics. Molecular diagnosis & therapy. 2011); 15(1): 53-55.
54. Kim J, Hong J, Park H. Prospects of deep learning for medical imaging. Precision and Future Medicine. 2018; 2(2): 37-52.
55. Bellazzi R, Ferrazzi F, Sacchi L. Predictive data mining in clinical medicine: a focus on selected methods and applications. Wiley Interdisciplinary Reviews: Data Mining and Knowledge Discovery. 2011; 1(5): 416-430.
56. Jiang F, Jiang Y, Zhi H, Dong Y, Li H, Ma S, Wang Y. Artificial intelligence in healthcare: Past, present and future. Stroke and Vascular Neurology. 2017; 2(4): 230-243.
57. Ker J, Lipo W, Rao J, Lim T. Deep learning applications in medical image analysis. IEEE Access. 2018; 6: 9375-9389.
58. Hu S, Gao Y, Niu Z, Jiang Y, Li L, Xiao X, Ye H. Weakly supervised deep learning for covid-19 infection detection and classification from ct images. IEEE Access. 2020; 8: 118869-118883.
59. Rojas R. Neural networks: a systematic introduction. Springer Science & Business Media. 2013.
60. Dietterich T. Overfitting and undercomputing in machine learning. ACM computing surveys (CSUR). 1995; 27(3): 326-327.
61. Chholak P, Niso G, Maksimenko VA, Kurkin SA, Frolov NS, Pitsik EN, Hramov AE, Pisarchik AN. Visual and kinesthetic modes affect motor imagery classification in untrained subjects. Scientific reports. 2019; 9(1): 1-12.
62. Barrett JH, Cairns D A. Application of the random forest classification method to peaks detected from mass spectrometric proteomic profiles of cancer patients and controls. Statistical Applications in Genetics and Molecular Biology. 2008; 7(2).
63. Fan S, Kind T, Cajka T, Hazen SL, Tang WW, Kaddurah-Daouk R, Fiehn O. Systematic error removal using random forest for normalizing large-scale untargeted lipidomics data. Analytical chemistry. 2019; 91(5): 3590-3596.
64. Adlassnig KP, Combi C, Das AK, Keravnou ET, Pozzi G. Temporal representation and reasoning in medicine: Research directions and challenges. Artificial intelligence in medicine. 2006; 38(2): 101-113.
65. Sternickel K. Automatic pattern recognition in ECG time series. Computer methods and programs in biomedicine. 2002; 68(2): 109-115.
66. Aldroubi A. Wavelets in medicine and biology. Routledge. 2017.
67. Hramov AE, Koronovskii AA, Makarov VA, Pavlov AN, Sitnikova E. Wavelets in neuroscience. Springer Berlin Heidelberg. 2015.
68. Maksimenko VA, van Heukelum S, Makarov VV, Kelderhuis J, Lüttjohann A, Koronovskii AA, Hramov AE, van Luijtelaar G. Absence seizure control by a brain computer interface. Scientific Reports. 2017; 7(1): 1-8.
69. Fournier-Viger P, Lin JCW, Kiran RU, Koh YS, Thomas R. A survey of sequential pattern mining. Data Science and Pattern Recognition. 2017; 1(1): 54-77.
70. Sethi A, Mahajan P. Association Rule Mining: A Review. International Journal of Computer Science. 2012; 1(9).
71. Shukla DP, Patel SB, Sen AK. A literature review in health informatics using data mining techniques. International Journal of Software and Hardware Research in Engineering. 2014; 2(2): 123-129.
72. Moskovitch R, Shahar Y. Medical temporal-knowledge discovery via temporal abstraction. In AMIA annual symposium proceedings. American Medical Informatics Association. 2009: 452).
73. Tu SW, Tennakoon L, O’Connor M, Shankar R, Das A. Using an integrated ontology and information model for querying and reasoning about phenotypes: the case of autism. In AMIA Annual Symposium Proceedings. American Medical Informatics Association. 2008: 727.
74. Jin H, Chen J, He H, Williams GJ, Kelman C, O’Keefe CM. Mining unexpected temporal associations: applications in detecting adverse drug reactions. IEEE Transactions on Information Technology in Biomedicine. 2008; 12(4): 488-500.
75. Chazard E, Preda C, Merlin B, Ficheur G, Beuscart R. Data-mining-based detection of adverse drug events. Stud Health Technol Inform. 2009; 150: 552-556.
76. Norén GN, Hopstadius J, Bate A, Star K, Edwards IR. Temporal pattern discovery in longitudinal electronic patient records. Data Mining and Knowledge Discovery. 2010; 20(3): 361-387.
77. Combi C, Franceschet M, Peron A. Representing and reasoning about temporal granularities. Journal of Logic and Computation. 2004; 14(1): 51-77.
78. Combi C, Pinciroli F, Pozzi G. Managing different time granularities of clinical information by an interval-based temporal data model. Methods of information in medicine. 1995; 34(05): 458-474.
79. Concaro S, Sacchi L, Cerra C, Stefanelli M, Fratino P, Bellazzi R. Temporal data mining for the assessment of the costs related to diabetes mellitus pharmacological treatment. In AMIA Annual Symposium Proceedings. American Medical Informatics Association. 2009: 119.
doi: 10.25881/18110193_2021_3_20.